Loading...

111, Inc.

YINASDAQ
Healthcare
Medical - Pharmaceuticals
$7.32
$-0.06(-0.81%)

Fundamental Analysis of 111, Inc. (YI)

Comprehensive financial metrics and ratios analysis
EPS (TTM)
$-2.17
P/E Ratio
-3.37
ROE
0.11%
Net Margin
-0.00%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$63.45M
Shares OutstandingTotal number of shares issued
$8.67M
Book Value/ShareNet worth per share
$21.83
Revenue/ShareAnnual revenue per share
$831.91

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$-2.17
Net MarginNet income as percentage of revenue
-0.48%
Operating MarginOperating income as percentage of revenue
-0.01%
ROEReturn on shareholders' equity
10.79%
ROAReturn on total assets
-2.63%
ROCEReturn on capital employed
-0.34%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$14.31
Cash/ShareCash and equivalents per share
$28.06
FCF YieldFree cash flow as percentage of market cap
55.79%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
-
Dividend YieldAnnual dividend as percentage of stock price
-
Financial Ratios Analysis data is not available for YIFinancial Ratios Analysis details for YI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for YISector Benchmarking details for YI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for 111, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of 111, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account 111, Inc.'s unique business strengths and challenges.

Key Financial Metrics for 111, Inc.

For 111, Inc., essential financial indicators include EPS -2.17, PE -3.37, and ROE 0.11. These key ratios reveal insights into 111, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare 111, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of 111, Inc.

Metrics like Net Margin -0.48% and ROA -2.63% shed light on how well 111, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether 111, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of 111, Inc.

Using ratios such as P/B Ratio -0.68 and PEG Ratio 0.002, investors can assess whether 111, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with 111, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for 111, Inc.

Financial health indicators, such as Debt/Equity Ratio -0.30 and Cash Flow $14.31, provide a snapshot of 111, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like 111, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for 111, Inc.

Investing in 111, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at 111, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;